Colliers on Monday announced it successfully brokered the sale of two significant office portfolios in Marlton, totaling more than 167,000 square feet. The transaction involved 1 & 3 Eves Drive and the Evesham Corporate Center, six buildings in total that were sold through a series of online auction events.
The deal highlights the continued demand for medical-centric office space in the South Jersey suburban market, particularly those with proximity to major regional health care hubs like Virtua Marlton Hospital and Jefferson Cherry Hill Hospital.
The sale was orchestrated by a Colliers team led by Jacklene Chesler, vice chair; Patrick Norris, vice president; and Brittany Leventoff, transaction manager.
1. 1 & 3 Eves Drive
- Size: ±33,317 square feet.
- Asset Type: Two adjacent single-story office buildings.
- Occupancy: 100% leased at the time of sale.
- Key Features: Private entrances for all suites and stable, long-term historical occupancy.
2. Evesham Corporate Center
- Size: ±133,822 square feet (Buildings 2, 4A, 4B, and 5 Eves Drive).
- Occupancy: 65.2% leased at the time of sale.
- Potential: The portfolio was marketed as a high-value “value-add” opportunity, offering immediate cash flow with significant upside through leasing and long-term repositioning.
Both properties are located along high-traffic retail corridors with rapid access to I-295 and the New Jersey Turnpike. This connectivity has made the Eves Drive corridor a magnet for healthcare-related tenants looking for flexible, accessible floor plates.
“The prime locations, coupled with the properties’ robust tenant bases and value-add potential, made them highly attractive investments,” Chesler said. “These sales reinforce Colliers’ momentum in New Jersey’s suburban office markets.”
This closing follows a series of successful health care-anchored transactions for Colliers across the state. In late 2025, the same team was tapped to arrange the sale of a vacant 66,500-square-foot office building in Bridgewater, signaling a robust pipeline for the firm heading into the mid-2026 fiscal year.
